Dr. J. (Bas) van Vlijmen

Relevante artikelen:

• ‘Overstap naar Biosimilars scheelt miljoenen’ Kees Noordam, Bas van Vlijmen, Johan Oltvoort, Medisch Contact 35, sept 2016 p18-20
• Erf S.van Boonzaaijer G., Heida JP; Evaluatie overheveling geneesmiddelen definitief, SIRM
• Beck – Peccoz P., Minuto F., Leal – Cerro A., Zabransky M., Stalla G.; Rationale and design of PATRO adults, a multicentre, noninterventional study of the long – term efficacy and safety of Omnitrope® for the treatment of adult patients with growth hormone deficiency; Ther Adv Endocrin Metab; 2012; 3, 85-91